Thyroid and Cardiovascular Disease: A Focused Review on the Impact of Hyperthyroidism in Heart Failure.
Cardiovascular
Heart failure
Hyperthyroidism
Thyroid
Journal
Cardiology research
ISSN: 1923-2829
Titre abrégé: Cardiol Res
Pays: Canada
ID NLM: 101557543
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
10
02
2020
accepted:
21
02
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
ppublish
Résumé
The association between thyroid hormones and cardiovascular conditions has been well studied, specifically, the effects of hypothyroidism on cardiomyopathy, and hyperthyroidism with arrhythmias. Nonetheless, an explicit correlation between hyperthyroidism and cardiomyopathy has yet to be established. Medical databases MEDLINE and PubMed were accessed and queried as primary sources for data acquisition. Search criteria consisted of "hyperthyroidism", "heart failure", and "thyroid and cardiovascular system", which allowed the retrieval of relevant and recent works. From these sources, a consensus was developed and employed to yield an updated review of the etiology of heart failure in the setting of hyperthyroidism. It is rare for patients with hyperthyroidism to remain in a chronic hyperthyroid state, making it difficult to analyze subsequent long-term effects on the cardiovascular system. Related to heart failure, some studies have demonstrated no change in ejection fraction, while others have shown an acute change along with diastolic dysfunction, with or without an underlying rhythm abnormality. Further investigation is warranted to elucidate the mechanism driving such cardiac dysfunction, and whether it is due to vascular changes, tachyarrhythmias, or myocyte remodeling and fibrosis. The intent of this review article is to improve our understanding of how a hyperthyroid state affects cardiovascular function. An enhanced understanding of the effects on cardiovascular physiology will afford physicians the ability to provide more comprehensive care in consideration of both endocrine and cardiovascular pathologies.
Identifiants
pubmed: 32256913
doi: 10.14740/cr1034
pmc: PMC7092768
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
68-75Informations de copyright
Copyright 2020, Khan et al.
Déclaration de conflit d'intérêts
There are no competing or conflicting interests associated with this article.
Références
Ann Intern Med. 2002 Dec 3;137(11):904-14
pubmed: 12458990
Thyroid. 2010 Apr;20(4):369-73
pubmed: 20210671
Heart. 2007 Apr;93(4):483-7
pubmed: 17005710
PLoS One. 2012;7(10):e46655
pubmed: 23056390
Cardiovasc Res. 2003 Jul 1;59(1):181-8
pubmed: 12829189
Clin Investig Arterioscler. 2014 Nov-Dec;26(6):296-309
pubmed: 25438971
Mol Cell Endocrinol. 2006 Feb 26;246(1-2):121-7
pubmed: 16442701
Metabolism. 1993 Aug;42(8):1059-64
pubmed: 8345811
Endocr Rev. 2005 Aug;26(5):704-28
pubmed: 15632316
Circulation. 2012 Aug 28;126(9):1040-9
pubmed: 22821943
J Clin Endocrinol Metab. 2005 Feb;90(2):673-7
pubmed: 15522926
Clin Med Insights Case Rep. 2013 Mar 27;6:47-50
pubmed: 23645990
PLoS One. 2011;6(9):e25054
pubmed: 21966411
J Clin Invest. 1931 Aug;10(3):475-87
pubmed: 16693993
Circulation. 2005 Nov 15;112(20):3122-30
pubmed: 16275864
J Mol Cell Cardiol. 1988 May;20(5):379-87
pubmed: 2974888
Arch Intern Med. 2008 Nov 10;168(20):2219-24
pubmed: 19001198
Cardiovasc Res. 2010 Feb 1;85(3):560-70
pubmed: 19734167
Am J Med. 2014 Aug;127(8):691-8
pubmed: 24662620
J Biol Chem. 2003 Apr 25;278(17):15073-83
pubmed: 12562779
J Am Coll Cardiol. 2008 Sep 30;52(14):1152-9
pubmed: 18804743
Circulation. 2009 Apr 14;119(14):1977-2016
pubmed: 19324967
Heart Vessels. 2015 Sep;30(5):642-6
pubmed: 24838983
N Engl J Med. 2001 Feb 15;344(7):501-9
pubmed: 11172193
Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):60-63
pubmed: 28740583
J Biol Chem. 2006 Jul 28;281(30):20666-72
pubmed: 16717100
N Engl J Med. 1994 Nov 10;331(19):1249-52
pubmed: 7935681
Hypertension. 2003 Mar;41(3):598-603
pubmed: 12623965
Arch Intern Med. 2000 Feb 28;160(4):526-34
pubmed: 10695693
JAMA. 2006 Mar 1;295(9):1033-41
pubmed: 16507804
Methodist Debakey Cardiovasc J. 2010 Apr-Jun;6(2):3-8
pubmed: 20661186
Ann Intern Med. 2004 Jan 20;140(2):128-41
pubmed: 14734337
Endocrinology. 2000 Jun;141(6):2139-44
pubmed: 10830301
Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1690-6
pubmed: 11557559
J Natl Med Assoc. 2008 Apr;100(4):401-5
pubmed: 18481478
J Am Coll Cardiol. 2012 Aug 21;60(8):730-7
pubmed: 22726629
J Mol Cell Cardiol. 2005 Nov;39(5):841-4
pubmed: 16171808
Mol Cell Endocrinol. 2003 Dec 31;213(1):1-11
pubmed: 15062569
J Clin Hypertens (Greenwich). 2006 Aug;8(8):596-9
pubmed: 16896276
Intern Med. 2018 Jun 15;57(12):1747-1749
pubmed: 29434126
JACC Heart Fail. 2013 Feb;1(1):48-55
pubmed: 24159562
Circulation. 2005 Sep 20;112(12):e154-235
pubmed: 16160202
Am J Med Sci. 2011 Dec;342(6):507-12
pubmed: 22112709
Br J Clin Pharmacol. 1998 Nov;46(5):421-4
pubmed: 9833593
Endocr Rev. 2008 Feb;29(1):76-131
pubmed: 17991805
Circ Res. 2008 Feb 29;102(4):439-47
pubmed: 18096819
Heart Fail Rev. 2010 Mar;15(2):155-69
pubmed: 19110971